Intravitreal therapeutic agents in noninfectious uveitic macular edema
The management of uveitis is challenging for most treating ophthalmologists. The treatment of uveitis often requires the use of high dose of systemic corticosteroid and immunosuppressive agents, which are almost always associated with potential side effects. Intravitreal medications have become a po...
Main Authors: | Kunal Kaushik Shah, Parthopratim Dutta Majumder, Jyotirmay Biswas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2018;volume=66;issue=8;spage=1060;epage=1073;aulast=Shah |
Similar Items
-
Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01) -
Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials
by: Lu Gao, et al.
Published: (2021-10-01) -
Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
by: Kubaisi B, et al.
Published: (2018-05-01) -
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022-11-01) -
Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema
by: Amit K. Reddy, et al.
Published: (2024-02-01)